Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. - Wikidata - wikimedia - TriplyDB

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

http://www.wikidata.org/entity/Q34496604

about

Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement Deletional and regulatory mechanisms coalesce to drive transplantation tolerance through mixed chimerism The use of novel diagnostics to individualize immunosuppression following transplantation Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis Banking on iPSC--is it doable and is it worthwhile Spontaneous restoration of transplantation tolerance after acute rejection.Splenocyte Infusion and Whole-Body Irradiation for Induction of Peripheral Tolerance in Porcine Lung Transplantation: Modifications of the Preconditioning Regime for Improved Clinical Feasibility Effect of tolerance versus chronic immunosuppression protocols on the quality of life of kidney transplant recipients.Notch-Expanded Murine Hematopoietic Stem and Progenitor Cells Mitigate Death from Lethal Radiation and Convey Immune Tolerance in Mismatched Recipients.Hand transplants and the mandate for tolerance.Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.Organ-specific differences in achieving tolerance Tolerance signatures in transplant recipients Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial.Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance.Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.Induced regulatory T cells in allograft tolerance via transient mixed chimerism.Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation.Incomplete clonal deletion as prerequisite for tissue-specific minor antigen tolerization.Stable mixed chimerism and tolerance to human organ transplants.Transient mixed chimerism for allograft tolerance.Donor-Specific Regulatory T Cells Acquired from Tolerant Mice Bearing Cardiac Allograft Promote Mixed Chimerism and Prolong Intestinal Allograft Survival.Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles.Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance.Haploidentical hematopoietic stem cell transplantation: state of art.Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation.Cell therapy for immunosuppression after kidney transplantation.Exploring cell-based tolerance strategies for hand and face transplantation.Post-transplantation malignancies: here today, gone tomorrow?Islet cell transplant: Update on current clinical trials.Facilitating cells: Translation of hematopoietic chimerism to achieve clinical tolerance A New Window into the Human Alloresponse.Mesenchymal stromal cells in renal transplantation: opportunities and challenges.Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.Immune monitoring in renal transplantation: The search for biomarkers.Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement.Transplantation tolerance after allograft rejection.

P2860

Q26769878-8F5E86A2-B4DD-4118-914E-E525F454B58E Q26801029-7F2D26AF-1183-43EE-B848-40B337ECE419 Q26864686-5CAB07F9-C525-4CB8-8C78-45E6545A1182 Q27012881-01E393D9-07C9-4A4B-AEE0-9F92B5ED4FB0 Q28084366-10F0006B-F451-4A05-9121-90F5545E5098 Q28254023-C8F747FD-66E1-40F2-94C6-C578CA65E5FC Q30657418-23F75069-BD1D-4E14-9B57-82D53EA37943 Q33443622-420A12C9-ADFC-446F-A2A1-555481AAD7BF Q33468225-97E9304C-C614-4C69-AED8-C38AE34CD0E0 Q33722553-C4C86DB3-341A-4CD4-AD08-8C699B056903 Q35157382-499CD6BF-8D3A-4C10-828E-2A67020CA3C5 Q35879079-C659E9A9-39AF-4F7E-983B-7FF36B1FC96E Q35911564-F88833FB-A4DA-4328-9941-20F2AD937365 Q35915308-AF4491B5-23EB-4199-B1CF-167C64B685CC Q36248860-0307C339-E2A5-4FB8-8F80-A49C538AE993 Q36262113-FC3882D3-8B75-4A0A-81D7-04AD7AADAEDE Q36498594-BE05E96A-EFE5-49A9-B372-24330BAF35D6 Q36727857-0061FAFD-8887-443A-B40F-29AFEFAC30A1 Q37098988-90A20F6F-9528-4D40-9499-8BF667BAB8CE Q37109198-9470C1A9-1EDE-4EE6-A560-41C4B47242B0 Q37243068-3620A53A-459D-408A-AC79-0584B075609F Q37277174-A7D2F652-57A7-4243-BC3A-0421FD0D8CAA Q37337098-F70D6D39-0E10-4071-9162-3CFAA040504E Q37340107-A619882D-4F69-4CC3-88CC-089995014B9E Q37419992-C93A4ECC-8600-464F-9EBB-FBD719540005 Q38256369-26271BD6-69B3-4C34-9B48-A61539587036 Q38309290-8157E731-ACCF-4EB9-A8F0-997068991E56 Q38514481-D3AF6939-A476-40DC-A7BE-2194E464AE48 Q38514510-A21DB19E-FE25-4080-BCCA-0E2224F0B5EA Q38528323-B25E58D3-805E-4195-9BD9-AA5642FC5FE0 Q38569715-17B3818A-C36A-4340-922D-D0AB93F181E6 Q38611709-50F96EFB-DA52-4156-AC9E-B1CAEE88A12C Q38689971-59B00E3F-B0A0-44E7-A6DE-A95AE1DC5830 Q38690514-6CF509C9-3B2B-4F29-9C4C-A6D35106B3B2 Q38694588-76B2209E-7EB8-4DC0-9EEB-D3EB0E6654B2 Q38725481-A109121B-D816-4771-929B-4EE438E72F80 Q38754342-ACE6622B-899D-421A-BCF8-FB2743A04706 Q38793766-B43BD5F4-1266-44B6-987D-C4CC8B993391 Q38967258-87C1483C-70CB-4F41-86FE-7C0ACFF19903 Q39023588-2A9D024F-82BC-4B6E-9D66-B0430E8E5EDD

P2860

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

http://www.wikidata.org/entity/Q34496604

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Long-term results in recipient ...... maintenance immunosuppression.

@ast

Long-term results in recipient ...... maintenance immunosuppression.

@en

Long-term results in recipient ...... maintenance immunosuppression.

@nl

type

label

Long-term results in recipient ...... maintenance immunosuppression.

@ast

Long-term results in recipient ...... maintenance immunosuppression.

@en

Long-term results in recipient ...... maintenance immunosuppression.

@nl

prefLabel

Long-term results in recipient ...... maintenance immunosuppression.

@ast

Long-term results in recipient ...... maintenance immunosuppression.

@en

Long-term results in recipient ...... maintenance immunosuppression.

@nl

P1433

Q34496604-248D21E5-7128-4CD4-8C33-689EFBDBF88A

P1476

Q34496604-036FCA2D-13C1-44B7-A2C0-B065D1ED5135

P2093

Q34496604-0440A09B-6C3B-47D6-B622-C4A577582F3C

Q34496604-10663B27-3656-4E22-9163-A7FFF08E1C80

Q34496604-25F3CDC0-252D-4097-A7D3-341245CECABE

Q34496604-2B056096-6095-4A96-8598-EFCF344C017C

Q34496604-369D7502-8911-42CC-AEF8-06FE9CF01A9A

Q34496604-5E6205EB-B9C3-43BC-8DA4-8EB4D64042FB

Q34496604-64C0A293-922E-4936-9C10-E4823E5624B8

Q34496604-8EB2ED08-0EED-40D0-837D-AB05DBAE5374

Q34496604-9263589B-C2BE-4DB6-AB5E-AB9406786881

Q34496604-9E8C63A3-F0D6-4FF4-8B8A-4F6C87B88297

P2860

Q34496604-068C5816-051F-4D3E-9522-E0F2628E2BAB

Q34496604-0972E85B-4BC3-4C7A-A849-26D36A38B667

Q34496604-10E4F9D0-956B-4B14-89B6-D15729873B48

Q34496604-226F00A9-C9CB-421E-962E-2B24905D8E93

Q34496604-3BE30DBA-E276-44E1-9BFE-69B535021F9C

Q34496604-452F7B58-2936-4736-8A14-E2E152F920EB

Q34496604-45F612AA-66F3-471E-93C3-FDF8D068520F

Q34496604-5073556F-D089-49F7-8410-BE63AA3DEF70

Q34496604-63F72EBC-CE5C-4284-AF47-0F4D958D3F6A

Q34496604-6F7D81FB-F1BC-405F-955A-4BC63F4786E3

P304

Q34496604-6CB68F89-A8F2-4F32-9AE4-740996F810B8

P31

Q34496604-C8662619-4742-416A-B5FD-7727A1A842C4

P356

Q34496604-9C6B2C12-0A7E-4EA3-AADC-C685D74C5080

P407

Q34496604-021607DE-A393-46EE-AAF3-FC5900BB4729

P433

Q34496604-2C4AB676-B45C-46C3-BEFE-8C693BCFD6AF

P478

Q34496604-89B25D05-E380-4493-9822-095F72CA9667

P50

Q34496604-83B43D79-7280-4804-A6ED-0F6436DE2C30

P577

Q34496604-67A44826-9BAD-42A4-9A2A-2EE80BCAF374

P5875

Q34496604-E3BCC79D-8AF1-405B-937C-18DC71FB9391

P698

Q34496604-4A603898-DEFF-4247-8AFB-C5CBB1E1862F

P921

Q34496604-6E195C50-B7EE-4881-B6A8-E75A7341BEEE

Q34496604-F8B33BB2-6B6C-4896-AD32-80815C5BF15F

P932

Q34496604-6A32ED4A-2B37-44DE-BBA2-90BC4077CF11

P356

P1433

American Journal of Transplantation

P1476

Long-term results in recipient ...... maintenance immunosuppression

@en

P2093

A B Cosimi

http://www.w3.org/2001/XMLSchema#string

B Gao

http://www.w3.org/2001/XMLSchema#string

B Shonts

http://www.w3.org/2001/XMLSchema#string

D H Sachs

http://www.w3.org/2001/XMLSchema#string

E Zorn

http://www.w3.org/2001/XMLSchema#string

F Preffer

http://www.w3.org/2001/XMLSchema#string

H Morris

http://www.w3.org/2001/XMLSchema#string

K Crisalli

http://www.w3.org/2001/XMLSchema#string

M Sykes

http://www.w3.org/2001/XMLSchema#string

N Tolkoff-Rubin

http://www.w3.org/2001/XMLSchema#string

P2860

HLA-mismatched renal transplantation without maintenance immunosuppression.

The metabolic effects of cyclosporin and tacrolimus.

Actively acquired tolerance of foreign cells.

Mixed chimerism and transplant tolerance.

Mixed chimerism.

Engraftment syndrome following hematopoietic stem cell transplantation.

Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.

Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance.

Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts.

Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease.

P304

1599-1611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.12731

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262928085

http://www.w3.org/2001/XMLSchema#string

P698

24903438

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

P932

4228952

http://www.w3.org/2001/XMLSchema#string